Teksta versija
LEGAL ACTS OF THE REPUBLIC OF LATVIA
home
 
Par GlaxoSmithKline Latvia SIA (Reģ.Nr.4000363303, Bruņinieku iela 5, Rīga, LV–1001) medikamentu Hycamtin pulveris infūziju šķīduma pagatavošanai 1mg Nr.1 un Hycamtin pulveris infūziju šķīduma pagatavošanai 4mg Nr.1 svītrošanu no Kompensējamo zāļu saraksta diagnozei "Sīkšūnu plaušu vēzis" (C34)

This document has not been officially translated by the State Language Centre.
 
Document information
Title: Par GlaxoSmithKline Latvia SIA (Reģ.Nr.4000363303, Bruņinieku iela 5, Rīga, LV–1001) medikamentu .. Status:
In force
in force
Issuer: Centre of Health Economics Type: decision Document number: 1003Adoption: 23.12.2009.Entry into force: 21.01.2010.Publication: Latvijas Vēstnesis, 11, 21.01.2010.
Related documents
  • Other related documents
203930
21.01.2010
136
0
  • Twitter
  • Facebook
  • Draugiem.lv
 
0
Latvijas Vestnesis, the official publisher
ensures legislative acts systematization
function on this site.
All Likumi.lv content is intended for information purposes.
About Likumi.lv
News archive
Useful links
For feedback
Contacts
Mobile version
Terms of service
Privacy policy
Cookies
Latvijas Vēstnesis "Everyone has the right to know about his or her rights."
Article 90 of the Constitution of the Republic of Latvia
© Official publisher "Latvijas Vēstnesis"